The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
9-oxo-3-(phenylethynyl)-9H-indeno[1,2-b]pyrazine-2-carbonitrile ID: ALA4540623
PubChem CID: 155549898
Max Phase: Preclinical
Molecular Formula: C20H9N3O
Molecular Weight: 307.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1nc2c(nc1C#Cc1ccccc1)-c1ccccc1C2=O
Standard InChI: InChI=1S/C20H9N3O/c21-12-17-16(11-10-13-6-2-1-3-7-13)22-18-14-8-4-5-9-15(14)20(24)19(18)23-17/h1-9H
Standard InChI Key: XTBCKKSJNUJCHS-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
4.3455 -19.2164 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3455 -17.5820 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0508 -17.9947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0552 -18.8084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6402 -18.8119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6403 -17.9948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8631 -17.7422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8630 -19.0643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3868 -18.4025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5775 -18.4848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2433 -19.2283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7246 -19.8903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5322 -19.8047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6093 -16.9654 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7586 -17.5863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4663 -17.1778 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7637 -19.2157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4721 -19.6230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1806 -20.0303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1801 -20.8477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8877 -21.2549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5957 -20.8450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5915 -20.0236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8834 -19.6201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 2 2 0
5 1 2 0
1 4 1 0
3 2 1 0
3 4 2 0
5 6 1 0
6 7 1 0
7 9 1 0
8 5 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
7 14 2 0
3 15 1 0
15 16 3 0
4 17 1 0
17 18 3 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 307.31Molecular Weight (Monoisotopic): 307.0746AlogP: 2.96#Rotatable Bonds: ┄Polar Surface Area: 66.64Molecular Species: ┄HBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.19CX LogD: 4.19Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.47Np Likeness Score: -0.59
References 1. Wu X, Li X, Li Z, Yu Y, You Q, Zhang X.. (2018) Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer., 61 (24): [PMID:30508483 ] [10.1021/acs.jmedchem.8b01424 ]